drug-resistance

Documents about drug-resistance

• Resistencia Microbiana a los Antibióticos: un Problema de Salud Creciente#189458Dialnet
• Resistance to Antibiotics in Patients Receiving Eye Injections#1008414ClinicalTrials.gov
• Эпиднадзор за устойчивостью к противомикробным препаратам в Европе, данные 2023 г.: краткий обзор#990422WHO IRIS
• Drug Resistance Factors In Healthcare-associated Pneumonia#287354ClinicalTrials.gov
• Environmental heterogeneity facilitates competitive suppression of drug resistance#319775bioRxiv / medRxiv
• Strategies for drug repurposing in COVID-19#336849ARPHA OAI-PMH Endpoint
• 14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection#451500ClinicalTrials.gov
• Presentation 2_HIV-1 molecular transmission networks among MSM in Ningxia, China (2018–2024): insights into local transmission dynamics and drug resistance.pptx#266439Figshare
• Table 1_HIV-1 molecular transmission networks among MSM in Ningxia, China (2018–2024): insights into local transmission dynamics and drug resistance.docx#266440Figshare
• Presentation 1_HIV-1 molecular transmission networks among MSM in Ningxia, China (2018–2024): insights into local transmission dynamics and drug resistance.pptx#266441Figshare
• Fighting the resistance to aminoglycoside antibiotics by inhibiting Aminoglycoside Phosphotransferases#262175HAL (France)
• A One Health Framework to Estimate the Cost of Antimicrobial Resistance#328017Scholarly Commons at Boston University School of Law
• Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance#994996ClinicalTrials.gov
• Microbiota as a modulator of drug response: targeting microbial-drug crosstalk in cancer therapy#120198Europe PMC
• Antimicrobial resistance in sexually transmitted infections beyond gonococcal infection#335985RCAAP
• Machine learning-based analysis of drug resistance mutations in <i>Mycobacterium tuberculosis</i>#358734PLOS
• Bacterial Transmission Dynamics Study#143605ClinicalTrials.gov
• Clinical Characteristics for the Critical Ill Patients With Klebsiella Pneumoniae Infection#429783ClinicalTrials.gov
• Gene context drift identifies drug targets to mitigate cancer treatment resistance#477166PubMed Central
• Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis#372702University of Pretoria Repository
• Operational planning of the SECURE initiative to improve access to essential antibiotics: meeting report, 27 June 2024#203867WHO IRIS
• Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections#154707ClinicalTrials.gov
• Accelerating antibiotic discovery through artificial intelligence#686355OpenAlex
• New Genomic Techniques and Management of Multidrug-resistant Tuberculosis#837481ClinicalTrials.gov
• Antimicrobial Consumption and Resistance Dynamics Across Healthcare Level: Global Evidence and Stewardship Implications#205533Europe PMC
• Antimicrobial Resistance Patterns and Predictors in &lt;i&gt;Helicobacter pylori&lt;/i&gt; Infection: A Real-World Cohort Study#246388Europe PMC
• Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)#845395ClinicalTrials.gov
• Ventilator Associated Pneumonia by Multi-Drug Resistant Organism#127650ClinicalTrials.gov
• Ensemble Optimal Control for Managing Drug Resistance in Cancer Therapies.#220936NCBI PubMed Central
• Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians#272370ClinicalTrials.gov
• Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)#471481ClinicalTrials.gov
• Malaria Genetic Surveillance#1009447ClinicalTrials.gov
• Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.#858751ClinicalTrials.gov
• Understanding Anti-tuberculous Drug Resistance Detection, Prevalence of Resistance-Conferring Mutations, and Population Dynamics of Mycobacterium Tuberculosis complex in a High HIV and Tuberculosis Setting#661871eScholarship
• Resistance to platinum-based cancer drugs: A special focus on epigenetic mechanisms#947657Repositorio de Universidad Autónoma de Chile.
• The Relationship between Urinary Tract Infections and Multidrug-Resistant Bacterial Pathogens Harbouring Antibiotic Resistance Genes among Infected Patients in Al-Rifai City, Thi-Qar Province#398823HAL (France)
• Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance#810234ClinicalTrials.gov
• The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens#683108ClinicalTrials.gov
• Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024.#121118NCBI PubMed Central
• Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions.#148229NCBI PubMed Central
• Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.#338520NCBI PubMed Central
• Gene context drift identifies drug targets to mitigate cancer treatment resistance.#455194NCBI PubMed Central
• Seizure relapse in new onset epilepsy: It is not always drug resistance.#615894NCBI PubMed Central
• Data Management and Sharing Plan for: Understanding Emerging artemisinin partner drug resistance in eastern Africa#672780UNC Dataverse Dataverse OAI Archive
• Enhancing azole activity in drug-resistant Candida albicans using novel 1,4-benzodiazepines#685091HAL (France)
• Molecular Surveillance of &lt;i&gt;Plasmodium vivax&lt;/i&gt; and &lt;i&gt;Plasmodium falciparum&lt;/i&gt; Drug Resistance Genes in the Republic of Korea: 2022-2025#246396Europe PMC
• Altered sphingolipid metabolism is associated with osimertinib resistance in non-small cell lung cancer#201215Spiral
• Antimicrobial resistance surveillance in the WHO European Region 2024: data 2023#361345WHO IRIS
• World Malaria Report 2025: Growing Biological Threats, Shrinking Resources#430290HAL (France)
• Sustained High Prevalence of Multiple Antimalarial Drug Resistance Markers in Uganda in 2023-24#13885bioRxiv / medRxiv